Study Data Show Premia Spine’s TOPS Spinal Arthroplasty System Is Cost-effective Compared with TLIF, Becomes Dominant Strategy over Time

Premia Spine has been working on an alternative to transforaminal lumbar interbody fusion (TLIF), and it has published data about the alternative TOPS System. The primary purpose of the TOPS System is to enable mobility and stability for patients who have spinal stenosis and degenerative spondylolisthesis. Their findings were published in Journal of Health Economics and Outcomes Research. Part of the analysis of the data included both an economic analysis and an effort to determine how cost effective it was compared to TLIF.

Participants were arbitrarily assigned to either have TOPS surgery or TLIF surgery under a clinical trial. Data was then analyzed by an independent group to offer a more objective understanding of the results. According to the findings of the third-party group, TOPS was more cost effective over the first year period. It also provides an improved quality of life compared to TLIF. As a result of this study, the FDA designated TOPS as a Breakthrough Device Designation, and is currently going through further clinical trials.

The initial findings suggest that it is more beneficial and less costly for patients, while being more cost-effective for providers for the treatment of spinal stenosis and degenerative spondylolisthesis. With over 100 million people suffering from these two issues every year, TOPS could provide a better method of treating a debilitating and painful condition.

If you would like to learn more about this change in strategies related to treating spinal stenosis and spondylolisthesis, you can find the article at Study Data Show Premia Spine’s TOPS Spinal Arthroplasty System Is Cost-effective Compared with TLIF, Becomes Dominant Strategy over Time. It includes links to some additional resources and studies in case you want to get into more details than are provided in the article.

Leave a Comment

Your email address will not be published.